๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases

โœ Scribed by Sevil Kamali; Ayse Cefle; Mehmet Sayarlioglu; Ahmet Gul; Murat Inanc; Lale Ocal; Orhan Aral; Meral Konice


Publisher
Springer
Year
2004
Tongue
English
Weight
182 KB
Volume
25
Category
Article
ISSN
0172-8172

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Failure of low-dose intravenous immunogl
โœ Keith S. Kanik; Cheryl H. Yarboro; Yaakov Naparstek; Paul H. Plotz; Ronald L. Wi ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 262 KB ๐Ÿ‘ 2 views

Treatment with high-dose (400 mg/kg/ day) intravenous immunoglobulin ( M g ) shows benefit in many autoimmune diseases but is very expensive. Low-dose M g has also been shown to be effective in inhibiting adjuvant arthritis in the rat. This pilot, randomized, double-blind, placebo-controlled trial w

Effect of high-dose intravenous immunogl
โœ Boyd M. Koffman; Marinos C. Dalakas ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 52 KB ๐Ÿ‘ 2 views

The effect of intravenous immunoglobulin (IVIG) on various laboratory values was measured immediately before and after completion of serial monthly infusions of IVIG (2 g/kg) or an equal volume of placebo over 3-12 months, in 46 patients with neuromuscular diseases participating in controlled trials